Search results for query: prostate

Educational Objectives In this activity, experts in prostate cancer discuss cardiovascular risk in patients receiving androgen-deprivation therapy (ADT). Upon completion of this activity, participants should be better able to: Evaluate the impacts of prostate cancer and ADT on...

Dr. Samantha Strumeier * There's absolutely no evidence that testosterone replacement therapy causes prostate cancer, there's a lack of long-term data but I think you know we have a lot more data keeps coming out over the years and we should really hone in on that...

...what she is doing now. We explore the impact of low testosterone in men on cancer treatment. One major area where this impacts the most is prostate cancer where we cause low testosterone with androgen deprivation therapy. What happens if testosterone stays low after the treatment finishes...

...man struggling with sides on standard LHRH-based ADT. * He is a PhD evolutionary biologist, former professor of anatomy and neurobiology, prostate cancer quality-of-life researcher, co-developer of an androgen deprivation education program, and a patient who has used transdermal estradiol...

Dr. Tarik Benidir and Dr. Ruchika Talwar discuss smarter use of repeat testing, patient education, and why age and prostate size are key context clues.

Most men who undergo a prostate biopsy may not have cancer found at all—and the bigger mistake may be rushing from a single elevated PSA straight to the needle. Dr. James Wysock, an NYU urologist with deep expertise in prostate cancer diagnostics and image-guided biopsy, explains why the modern...

...benefits in metastatic PCa, yet TTh failed to demonstrate adverse PCa outcomes. The evidence showed that maximal androgen-stimulated prostate activity was reached at the relatively low T concentration of approximately 250 ng/dL (8.7 nmol/L), termed the saturation point, 8 with some...

In this episode, Dr. Brandon & Dr. Morgentaler talk about what high PSA levels really mean, their relationship to prostate cancer, and why an elevated PSA doesn’t necessarily rule out testosterone therapy after proper evaluation. Timestamps 00:00 PSA Basics Explained — PSA is a normal...

* “Active surveillance is about safely managing low-risk prostate cancer while preserving quality of life,” said Sanoj Punnen, M.D., professor of urologic oncology at the Miller School and DSUI vice chair of research. “For some men, maintaining quality of life may include testosterone...

...detection of indolent disease. 04:03 - Why PSA Can Be Misleading 06:43 - Approach to Elevated PSA and Initial Workup Is an elevated prostate-specific antigen (PSA) the beginning or the end of the prostate cancer workup? On this episode of BackTable Urology, Dr. Ruchika Talwar...

If you've been told you need a prostate biopsy, you may be wondering whether a transrectal biopsy or a transperineal biopsy is the better option. In this episode of UroPatient, Vic Senese, RN, BSN, FAUNA, explains the key differences between these two prostate biopsy techniques and what current...

...recently became the tip of the spear for a new era in oncological care. A resident of Liverpool and a veteran of a decade-long battle with prostate cancer, Perry made history on July 31st as the first patient in the United States to receive a newly expanded precision treatment. After ten...

Learning Objectives Take Home Points

...urologist whose lab work on nitric oxide led to the science behind Viagra, joined me for a frank conversation about men's sexual health, prostate cancer surgery, and why so many men never mention any of it to a doctor. He explains why he almost calls it penile vascular dysfunction, what the...

The AUA has released a major new guideline for the Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia — the most comprehensive update in years. With 62 recommendations covering everything from medical management to minimally invasive procedures, there's a lot...

Abraham Morgentaler, MD, joins Neil Baum, MD, to discuss the historical origins of the belief that testosterone drives prostate cancer and the new framework presented in his recent Journal of Urology publication.

...Taken together, the absence of testosterone recovery seems to be associated with worse overall survival. Dr. Tombal concluded his presentation discussing the importance of baseline testosterone and testosterone recovery by emphasizing that testosterone matters and we should be measuring it...

...Chief of Radiation Oncology, Baylor College of Medicine, Houston, Texas, presents an in-depth review of rectal spacing devices in modern prostate radiation therapy. He explains how dose-volume relationships drive rectal toxicity and how rectal spacers improve bowel and sexual quality of life...

...in the United States. Known for his surgical precision, exceptional patient outcomes, and commitment to advancing minimally invasive prostate care, Dr. Slade is sought out by patients and referring physicians from across the United States and around the world for the treatment of enlarged...

...only been one randomized study testing BAT 14:05 Stop & Watch: The TRANSFORMER trial—did BAT actually work? For decades, men with prostate cancer have been told that testosterone is like gasoline on a fire. But what if, under the right conditions, testosterone could actually become...

Candel pherapeutics, Prostate cancer play BLA submission is planned for Q4 2026, and if approved, it would be the first new therapy added to standard radiotherapy for localized prostate cancer in more than 20 years. The drug already holds Fast Track and RMAT designations

LEARNING OBJECTIVES: After participating in this educational series, participants will be able to: 1. Utilize the newly released AUA Guidelines Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia in practice. 2. Discuss the evidence base for current...

...Medicine and Assistant Professor of Urology, Indiana University, Carmel, Indiana, presents a review of testosterone therapy in men with prostate cancer, focusing on current evidence and clinical management. She examines the historical belief that testosterone promotes prostate cancer...

How do you protect your prostate, recognize the early signs of erectile dysfunction, and separate medical facts from internet myths? In this episode, Tom (he/him) sits down with Dr. Arthur Burnett (he/him), renowned Johns Hopkins urologist, researcher, and one of the pioneers behind the science...

In this episode of Pearls & Perspectives, host Amy Pearlman, MD, is joined by Larry Lipshultz, MD; Diane K. Newman, DNP, FAAN, BCB-PMD; and Stuart Hart, MD, MBA, MS, to discuss unmet needs surrounding lower urinary tract symptoms (LUTS) and the potential role of digital health in expanding...

...and Dr. Morgentaler talk about the FDA's groundbreaking testosterone label changes, the evolving evidence on testosterone therapy and prostate cancer, and how quality of life should factor into treatment decisions for men with advanced disease. Time stamps: 00:00 Listener Question...

The FDA's proposed narrowing of the testosterone therapy prostate cancer contraindication to metastatic disease only reflects current clinical evidence, opening the door to testosterone therapy in appropriately selected men with treated localized prostate cancer or on active surveillance, with...

AUA Guidelines: Advanced Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Kristen R. Scarpato, MD, MPH https://www.auanet.org/guidelines-and-quality/guidelines/advanced-prostate-cancer

Chapters 00:00 Introduction 00:23 Hormone Therapy and Sexual Function 04:06 Penile Shrinkage During Hormone Therapy 05:12 Cialis and Viagra During ADT 05:31 When to Start Cialis or Viagra 05:51 Is It Too Late to Restore Erectile Function? 06:34 When Cialis or Viagra Aren't Enough 07:25 What If...

...and Dr. Morgentaler talk about navigating sexual differences in relationships, the latest evidence supporting testosterone therapy after prostate cancer treatment, and practical ways couples can rebuild intimacy and sexual confidence during recovery. 00:00 – Welcome and Setup The hosts...

In this eye-opening episode of the Dr. Geo Prostate Podcast, Dr. Geo sits down with world-renowned exercise oncology researcher Professor Robert Newton, founder of the Exercise Medicine Research Institute and one of the leading voices in cancer exercise science. Discover why exercise is now...